Radiotherapy with a Radiolabeled Somatostatin Analogue, [111In‐DTPA‐d‐Phe1]‐Octreotide
- 1 September 1994
- journal article
- case report
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 733 (1), 496-506
- https://doi.org/10.1111/j.1749-6632.1994.tb17300.x
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Somatostatin-receptor imaging of human malignancies: A new era in the localization, staging, and treatment of tumorsGastroenterology, 1993
- Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow SupportNew England Journal of Medicine, 1993
- Radioimmunotherapy of B-Cell Lymphoma with [131I]Anti-B1 (Anti-CD20) AntibodyNew England Journal of Medicine, 1993
- Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1993
- Amino acid infusion blocks renal tubular uptake of an indium-labelled somatostatin analogueBritish Journal of Cancer, 1993
- [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validationLife Sciences, 1991
- Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasmsCancer, 1991
- The development of new radiopharmaceuticalsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1990
- Effects of immunoscintigraphy with monoclonal antibodies in assays of hormones and tumour markers.BMJ, 1989
- LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATINThe Lancet, 1989